International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant.

MLA

Garcia-Rosa, Moises, et al. “International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular Therapies for the Treatment of Graft-versus-Host-Disease after Hematopoietic Stem Cell Transplant.” Cytotherapy, vol. 25, no. 6, June 2023, pp. 578–89. EBSCOhost, https://doi.org/10.1016/j.jcyt.2023.02.007.

APA

Garcia-Rosa, M., Abraham, A., Bertaina, A., Bhoopalan, S. V., Bonfim, C., Cohen, S., DeZern, A., Louis, C., Oved, J., Pavel-Dinu, M., Purtill, D., Ruggeri, A., Russell, A., Sharma, A., Wynn, R., Boelens, J. J., & Prockop, S. (2023). International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant. Cytotherapy, 25(6), 578–589. https://doi.org/10.1016/j.jcyt.2023.02.007

Chicago

Garcia-Rosa, Moises, Allistair Abraham, Alice Bertaina, Senthil Velan Bhoopalan, Carmem Bonfim, Sandra Cohen, Amy DeZern, et al. 2023. “International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular Therapies for the Treatment of Graft-versus-Host-Disease after Hematopoietic Stem Cell Transplant.” Cytotherapy 25 (6): 578–89. doi:10.1016/j.jcyt.2023.02.007.